NCT04240574 is a NA clinical trial of Debritom in Diabetic Foot Ulcer, sponsored by Stephanie Wu.

Who is sponsoring NCT04240574?

NCT04240574 is sponsored by Stephanie Wu.

What drugs are being tested in NCT04240574?

Interventions in NCT04240574: Debritom.

What condition does NCT04240574 study?

NCT04240574 studies Diabetic Foot Ulcer, Non-healing Wound, Non-Healing Ulcer of Skin, Venous Leg Ulcer, Venous Ulcer.

Is NCT04240574 still recruiting?

NCT04240574 is currently terminated. Last updated 27 March 2023.

Are results published for NCT04240574?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-03-27 · How we verify

NCT04240574

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Debritom - Micro Water Jet Technology and Wound Healing

Terminated NA Results posted Last updated 27 March 2023

What this trial tests

NA trial testing Debritom in Diabetic Foot Ulcer in 2 participants. Terminated before completion.

Timeline

24 January 2020

Primary endpoint
6 August 2021

6 August 2021

Quick facts

Lead sponsor	Stephanie Wu
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	2
Start date	24 January 2020
Primary completion	6 August 2021
Estimated completion	6 August 2021
Sites	1 location across United States

Drugs / interventions tested

Debritom

Conditions studied

Diabetic Foot Ulcer — all drugs for Diabetic Foot Ulcer →
Non-healing Wound — all drugs for Non-healing Wound →
Non-Healing Ulcer of Skin — all drugs for Non-Healing Ulcer of Skin →
Venous Leg Ulcer — all drugs for Venous Leg Ulcer →

Sponsor

Stephanie Wu

Who can join

18 and older, any sex, with Diabetic Foot Ulcer or Non-healing Wound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate the clinical efficacy of micro water jet technology in the debridement and healing of chronic lower extremity ulcers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetic Foot Ulcer

Currently open trials in the same condition.

NCT07161830 — Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers · NA · recruiting
NCT07396376 — Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers · Phase 1, PHASE2 · recruiting
NCT07291817 — Intermittent Negative Pressure for Patients With Diabetic Foot Ulcers (INPRESS) Study · NA · recruiting
NCT07209358 — EDX110 Randomized Control Trial for Treatment of DFUs · NA · recruiting
NCT06938685 — Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04240574 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stephanie Wu
Last refreshed: 27 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04240574.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing